Cargando…
NT5DC2 promotes tumor cell proliferation by stabilizing EGFR in hepatocellular carcinoma
Most hepatocellular carcinoma (HCC) patients are diagnosed at an advanced stage; however, the effect of systemic therapy on advanced HCC remains undetermined. Therefore, new treatment targets must be identified. We analyzed Gene Expression Omnibus datasets from two HCC patient cohorts and found that...
Autores principales: | Li, Kang-Shuai, Zhu, Xiao-Dong, Liu, Hong-Da, Zhang, Shi-Zhe, Li, Xiao-Long, Xiao, Nan, Liu, Xue-Feng, Xu, Bin, Lei, Ming, Zhang, Yuan-Yuan, Shi, Wen-Kai, Cao, Man-Qing, Xu, Yun-Fei, Tang, Zhao-You, Sun, Hui-Chuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7206140/ https://www.ncbi.nlm.nih.gov/pubmed/32382041 http://dx.doi.org/10.1038/s41419-020-2549-2 |
Ejemplares similares
-
Comprehensive Analysis of Prognostic Value and Immune Infiltration of the NT5DC Family in Hepatocellular Carcinoma
por: Li, Rongqi, et al.
Publicado: (2022) -
NT5DC2 is a novel prognostic marker in human hepatocellular carcinoma
por: Chen, Jiemin, et al.
Publicado: (2020) -
PFKFB3 blockade inhibits hepatocellular carcinoma growth by impairing DNA repair through AKT
por: Shi, Wen-Kai, et al.
Publicado: (2018) -
Comprehensive analysis of NT5DC family prognostic and immune significance in breast cancer
por: Jia, Yiwei, et al.
Publicado: (2023) -
Rage induces hepatocellular carcinoma proliferation and sorafenib resistance by modulating autophagy
por: Li, Jun, et al.
Publicado: (2018)